Compare UTZ & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UTZ | VALN |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 912.7M | 875.7M |
| IPO Year | 2018 | 2021 |
| Metric | UTZ | VALN |
|---|---|---|
| Price | $7.56 | $10.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $13.00 | ★ $15.75 |
| AVG Volume (30 Days) | ★ 1.9M | 17.9K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,438,800,000.00 | N/A |
| Revenue This Year | $4.95 | $2.58 |
| Revenue Next Year | $1.59 | $4.43 |
| P/E Ratio | $730.00 | ★ N/A |
| Revenue Growth | ★ 2.09 | N/A |
| 52 Week Low | $7.26 | $5.43 |
| 52 Week High | $14.67 | $12.25 |
| Indicator | UTZ | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 26.63 | 48.35 |
| Support Level | N/A | $9.85 |
| Resistance Level | $10.74 | $10.46 |
| Average True Range (ATR) | 0.26 | 0.41 |
| MACD | -0.15 | -0.10 |
| Stochastic Oscillator | 11.17 | 18.35 |
Utz Brands Inc is a manufacturer of branded salty snacks. It produces a broad offering of salty snacks, including potato chips, tortilla chips, pretzels, cheese snacks, pork skins, pub/party mixes, and other snacks. Its iconic portfolio of authentic, craft, and better-for-you (BFY) brands, which includes Utz, Zapp's, On The Border, Golden Flake, and Boulder Canyon, among others, enjoys household penetration in the United States, where its products can be found in approximately half of U.S. household. The company operates in eight manufacturing facilities with a broad range of capabilities, and its products are distributed nationally to grocery, mass, club, convenience, drug, e-commerce and other retailers through direct shipments, distributors, and approximately 2,500 DSD routes.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.